Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Comvita Limited, along with its associated entities, specializes in the global production and distribution of natural health products. The company boasts a significant international presence, operating across diverse markets in Australasia, Asia (including China), North America, Europe, the Middle East, and Africa. Its extensive product portfolio features flagship items such as Manuka honey, propolis, and olive leaf extract. Additionally, it offers a wide array of medihoney, skincare, gourmet honey, elixirs, lozenges, and cider vinegar formulations, as well as dedicated solutions for oral and children's health. Comvita's range is meticulously designed to address diverse wellness needs, including supporting digestive health, soothing eczema-prone skin, boosting energy levels, promoting cardiovascular well-being, and fortifying immune support. The company also provides essential solutions for summer and travel requirements. Beyond product development, Comvita maintains a vertically integrated operational model, encompassing the ownership and management of apiaries (beekeeping operations), property assets, and valuable intellectual property. Established in 1974, Comvita Limited is headquartered in Te Puke, New Zealand.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, underpriced on P/FC.
Target Price
The average target price of CVT.NZ is 0.80 and suggests 19% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr